Canandaigua National Corp Pfizer Inc Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Pfizer Inc stock. As of the latest transaction made, Canandaigua National Corp holds 203,735 shares of PFE stock, worth $5.66 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares

203,735

Previous 196,752 3.55%

Holding current value

$5.66 Million

Previous $8.61 Million 21.24%

% of portfolio

1.77%

Previous 1.53%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $291,540 - $380,573	6,983 Added 3.55%	203,735 $10.4 Million
Q3 2022 Oct 05, 2022	BUY	$43.76 - $53.42 $139,550 - $170,356	3,189 Added 1.65%	196,752 $8.61 Million
Q2 2022 Jul 05, 2022	SELL	$46.53 - $55.17 $95,246 - $112,932	-2,047 Reduced 1.05%	193,563 $10.1 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $2.12 Million - $2.62 Million	46,253 Added 30.97%	195,610 $10.1 Million
Q4 2021 Jan 04, 2022	SELL	$41.32 - $61.25 $16,693 - $24,745	-404 Reduced 0.27%	149,357 $8.82 Million

Q3 2021 Oct 04, 2021	SELL	$39.25 - $50.42 $161,474 - $207,427	-4,114 Reduced 2.67%	149,761 $6.44 Million
Q2 2021 Jul 06, 2021	SELL	$35.91 - $40.68 $80,115 - $90,757	-2,231 Reduced 1.43%	153,875 $6.03 Million
Q1 2021 Apr 05, 2021	SELL	$33.49 - $37.77 $155,561 - $175,441	-4,645 Reduced 2.89%	156,106 $5.66 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $912,325 - $1.16 Million	-27,258 Reduced 14.5%	160,751 $5.92 Million
Q3 2020 Oct 19, 2020	SELL	$31.75 - $37.25 $540,099 - $633,659	-17,011 Reduced 8.3%	188,009 $6.9 Million
Q2 2020 Jul 07, 2020	BUY	$30.12 - $36.54 $6.18 Million - $7.49 Million	205,020 New	205,020 $6.7 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Pfizer Inc Transaction History